Publication | Open Access

Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial

Hematological MalignancyLymphoid NeoplasiaHealth SciencesElderly PatientsMedicineImmunologyClinical TrialsPhase 1B/2Immune Checkpoint InhibitorPharmacotherapyImmunotherapyOncologyRadiation OncologyInitial Therapy